1Farrow DC, Vaughan TL, Hansten PD. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gasteic cancer. Cancer Epdemiol Biomarkers Prey, 1998,7:97-110.
2Kune GA, Watson LF. Colorectal cancer risk, chronic illness, operations,and medications:case control from the melburne colorectal cancer study. Cancer Res, 1988,48:4399-4404.
3Travalis, Ku D, Rizzo MG, et al. Structure of human gene for the proliferating cell nuclear antigen. J Bio Chem, 1989,264:7460-7472.
4Bravo R, Frank R, Blundell PA, et al. Cyelin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature, 1987,326:515-517.
5Stolina M, Sharma S, Lin Y,et al. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL- 12 synthesis. J Immunol,2000,164:361-370.
6Farrow B, Evers BM. Inflammation and the Development of Pancreatic Cancer. Surg Oncol,2002, 10 : 153-169.
7Abiru S, Nakao K, lchikawa T, et al. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Hepatology ,2002,35 : 1117-1124.
8Araki Y, Okamura S, Hussain SP,et al. Regulation of cyclooxygenase- 2 expression by the Wnt and ras pathways. Cance Res,2003 ,63 :728- 734.
9Tayal V,Kalra BS. Cytokines and anti-cytokines as therapeutics:an update[J].European Journal of Pharmacology,2008,(1/3):1-12.doi:10.1016/j.ejphar.2007.10.049.
10Qu LS,Jin F,Huang XW. Interferon-α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus-related hepatocellular carcinoma[J].Journal of Surgical Oncology,2010.796-801.doi:10.1002/jso.21741.
